Background: Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia syndrome (FMS) are significant health problems with unclear aetiology. Although CWP and FMS can alter both central and peripheral pain mechanisms, there are no validated markers for such alterations. Pro-and anti-inflammatory components of the immune system such as cytokines and endogenous lipid mediators could serve as systemic markers of alterations in chronic pain. Lipid mediators associated with anti-inflammatory qualities - e.g., oleoylethanolamide (OEA), palmitoylethanolamide ( PEA), and stearoylethanolamide ( SEA) - belong to N-acylethanolamines (NAEs). Previous studies have concluded that these lipid mediators may modulate pain and inf...
Fibromyalgia (FMS) is a chronic pain syndrome with a complex but poorly understood pathogenesis affe...
Background: Chronic pain is a common condition, affecting a high percentage of the population. Fibro...
Introduction: Obesity is a common comorbidity in fibromyalgia (FM). Both FM and obesity have been co...
Background: Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia s...
Although chronic widespread musculoskeletal pain is a significant health problem, the molecular mech...
Objectives: This study aims to evaluate the differences in serum levels of tumor necrosis factor-alp...
This cross-sectional study investigates the plasma inflammatory profile of chronic widespread pain C...
Introduction: Little is still known about the underlying mechanisms that drive and maintain neuropat...
In Europe, approximately one in five adults experience chronic pain, pain that lasts more than three...
Bioactive lipids or lipids that activate specific signalling pathways are involved in the regulation...
International audienceBackground: Considering the role of metabolic diseases in osteoarthritis (OA),...
Objectives: The aetiology of primary chronic pain syndromes (CPS) is highly disputed. We performed ...
Lipid mediators have been suggested to have a role in pain sensitivity and response; however, longit...
Chronic widespread pain (CWP) is a complex pain condition that is difficult to treat. The prevalence...
Fibromyalgia (FMS) is a chronic pain syndrome with a complex but poorly understood pathogenesis affe...
Background: Chronic pain is a common condition, affecting a high percentage of the population. Fibro...
Introduction: Obesity is a common comorbidity in fibromyalgia (FM). Both FM and obesity have been co...
Background: Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia s...
Although chronic widespread musculoskeletal pain is a significant health problem, the molecular mech...
Objectives: This study aims to evaluate the differences in serum levels of tumor necrosis factor-alp...
This cross-sectional study investigates the plasma inflammatory profile of chronic widespread pain C...
Introduction: Little is still known about the underlying mechanisms that drive and maintain neuropat...
In Europe, approximately one in five adults experience chronic pain, pain that lasts more than three...
Bioactive lipids or lipids that activate specific signalling pathways are involved in the regulation...
International audienceBackground: Considering the role of metabolic diseases in osteoarthritis (OA),...
Objectives: The aetiology of primary chronic pain syndromes (CPS) is highly disputed. We performed ...
Lipid mediators have been suggested to have a role in pain sensitivity and response; however, longit...
Chronic widespread pain (CWP) is a complex pain condition that is difficult to treat. The prevalence...
Fibromyalgia (FMS) is a chronic pain syndrome with a complex but poorly understood pathogenesis affe...
Background: Chronic pain is a common condition, affecting a high percentage of the population. Fibro...
Introduction: Obesity is a common comorbidity in fibromyalgia (FM). Both FM and obesity have been co...